Sign in

    Mitch Moore

    Research Analyst at KeyBanc Capital Markets Inc.

    Mitch Moore is an Associate Analyst at KeyBanc Capital Markets Inc., specializing in equity research with a focus on technology and financial services sectors. Since joining KeyBanc in 2021, he has supported investment recommendations in both primary and secondary markets, though specific companies covered and quantitative performance metrics are not publicly disclosed. Previously, he served as a Financial Representative at The Northwestern Mutual Life Insurance Company from 2016 to 2017, and holds a graduate degree from the State University of New York at Buffalo (2020) as well as an undergraduate degree from the University at Buffalo (2018). Moore is registered with FINRA and works at a regulated broker-dealer, underscoring his professional credentials in investment finance.

    Mitch Moore's questions to REGAL REXNORD (RRX) leadership

    Mitch Moore's questions to REGAL REXNORD (RRX) leadership • Q4 2024

    Question

    Mitch Moore of KeyBanc Capital Markets inquired if the 2024 synergy upside was a pull-forward or an increase to the total opportunity, and asked about the company's manufacturing footprint in Mexico amid potential tariff risks.

    Answer

    CFO Rob Rehard clarified that the 2024 synergy outperformance was a pull-forward from 2025, with the total opportunity remaining the same. CEO Louis Pinkham stated that over 30% of the direct labor force is in Mexico and a dedicated team is managing potential tariff impacts through a flexible global footprint, operational efficiencies, and potential price actions, citing past experience and their 'in region for region' strategy.

    Ask Fintool Equity Research AI

    Mitch Moore's questions to Hillenbrand (HI) leadership

    Mitch Moore's questions to Hillenbrand (HI) leadership • Q4 2024

    Question

    Mitch Moore asked about the specific factors that drove Q4 results above guidance and questioned the rationale for the flat sales guidance for the MTS segment in fiscal 2025, given signs of stabilization.

    Answer

    CFO Bob VanHimbergen explained that the Q4 beat was driven by stronger-than-expected revenue in both the APS segment (particularly FPM and aftermarket) and the MTS segment (injection molding in the Americas and India). He clarified that the flat MTS sales guidance for fiscal 2025 reflects caution due to interest rate uncertainty and market volatility, despite recent stabilization. He also highlighted that MTS margins are expected to improve due to realized restructuring benefits.

    Ask Fintool Equity Research AI